The relation between efavirenz versus nevirapine and virologic failure in Johannesburg, South Africa

Journal of the International AIDS Society

Volumn 17, Issue , 2014, Pages

  Shearer, Kate ^a   Brennan, Alana T ^b   Maskew, Mhairi ^a   Long, Lawrence ^a   Berhanu, Rebecca ^c   Sanne, Ian ^a,b,c   Fox, Matthew P ^a,b,d  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b BOSTON UNIVERSITY SCHOOL OF PUBLIC HEALTH   (United States)

^c RIGHT TO CARE   (South Africa)

^d BOSTON UNIVERSITY   (United States)

Author keywords

Efavirenz; Loss to follow up; Mortality; Nevirapine; Resource limited settings; Viral suppression; Virologic failure

Indexed keywords

EFAVIRENZ; LAMIVUDINE; NEVIRAPINE; STAVUDINE; TENOFOVIR; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BENZOXAZINE DERIVATIVE;

ADULT; ANEMIA; ANTIRETROVIRAL THERAPY; ANTIVIRAL THERAPY; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; DEATH; DISEASE ASSOCIATION; DRUG TREATMENT FAILURE; FEMALE; FOLLOW UP; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PATIENT; PATIENT RISK; RISK ASSESSMENT; SENSITIVITY ANALYSIS; SINGLE DRUG DOSE; SOUTH AFRICA; TREATMENT RESPONSE; VIROLOGIC FAILURE; VIROLOGY; VIRUS LOAD; ADOLESCENT; COMPARATIVE STUDY; HIV INFECTIONS; ISOLATION AND PURIFICATION; MIDDLE AGED; TREATMENT FAILURE; VIREMIA; YOUNG ADULT;

ADOLESCENT; ADULT; ANTI-HIV AGENTS; BENZOXAZINES; FEMALE; FOLLOW-UP STUDIES; HIV; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; NEVIRAPINE; SOUTH AFRICA; TREATMENT FAILURE; VIREMIA; YOUNG ADULT;

EID: 84908252052     PISSN: None     EISSN: 17582652     Source Type: Journal    
DOI: 10.7448/IAS.17.1.19065     Document Type: Article

References (24)

1. WHO. Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection: recommendations for a public health approach. Geneva: WHO; 2013.
2. National Department of Health Republic of South Africa. The South African antiretroviral treatment guidelines. Pretoria: National Department of Health Republic of South Africa; 2013.
3. National Department of Health Republic of South Africa. Clinical guidelines for the management of HIV & AIDS in adults and adolescents. Pretoria: National Department of Health Republic of South Africa; 2010.
4. WHO. Antiretroviral therapy for HIV infection in adults and adolescents: recommendations for a public health approach-2010 revision. Geneva: WHO; 2010.
5. National Drug and Therapeutics Policy Advisory Committee (NDTPAC) and the AIDS and TB Unit Ministry of Health and Child Welfare. Guidelines for antiretroviral therapy in Zimbabwe, 2010. Harare: NDTPAC and MOHCW; 2010.
6. Republic of Namibia Ministry of Health and Social Services. National guidelines for antiretroviral therapy. 3rd ed. Windhoek: Republic of Namibia Ministry of Health and Social Services; 2010.
7. Nigerian Federal Ministry of Health. National guidelines for HIV and AIDS treatment and care in adolescents and adults. Abuja: Nigerian Federal Ministry of Health; 2010.
8. Republic of Uganda Ministry of Health. The integrated national guidelines on antiretroviral therapy, prevention of monther to child transmission of HIV and infant & young child feeding. Kampala: Uganda Ministry of Health; 2011.
9. The HIV-CAUSAL Collaboration. The effect of efavirenz versus nevirapinecontaining regimens on immunologic, virologic and clinical outcomes in a prospective observational study. AIDS. 2012;26:1691-705.
10. Van den Berg-Wolf M, Hullsiek KH, Peng G, Kozal MJ, Novak RM, Chen L, et al. Virologic, immunologic, clinical, safety, and resistance outcomes from a long-term comparison of efavirenz-based versus nevirapine-based antiretroviral regimens as initial therapy in HIV-1-infected persons. HIV Clin Trials. 2008;9:324-36.
11. Tang MW, Kanki PJ, Shafer RW. A review of the virological efficacy of the 4 World Health Organization-recommended tenofovir-containing regimens for initial HIV therapy. Clin Infect Dis. 2012;54:862-75.
12. Nachega JB, Hislop M, Dowdy DW, Gallant JE, Chaisson RE, Regensberg L, et al. Efavirenz versus nevirapine-based initial treatment of HIV infection: clinical and virological outcomes in Southern African adults. AIDS. 2008; 22:2117-25.
13. Shearer K, Fox MP, Maskew M, Berhanu R, Long L, Sanne I. The impact of choice of NNRTI on short-term treatment outcomes among HIV-infected patients prescribed tenofovir and lamivudine in Johannesburg, South Africa. PLoS One. 2013;8:e71719.
14. Fox MP, Maskew M, Macphail AP, Long L, Brennan AT, Westreich D, et al. Cohort profile: the Themba Lethu Clinical Cohort, Johannesburg, South Africa. Int J Epidemiol. 2013;42:430-9.
15. National Department of Health Republic of South Africa. National antiretroviral treatment guidelines. Pretoria: Jacana; 2004.
16. Fox MP, Brennan A, Maskew M, MacPhail P, Sanne I. Using vital registration data to update mortality among patients lost to follow-up from ART programmes: evidence from the Themba Lethu Clinic, South Africa. Trop Med Int Heal. 2010;15:405-13.
17. WHO. Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. Vitamin and Mineral Nutrition Information System. Geneva: World Health Organization; 2011 p. (WHO/NMH/NHD/MNM/11.1).
18. Lash TL, Fox MP, Fink AK. Applying quantitative bias analysis to epidemiologic data. Springer Science-Business Media, LLC; 2009.
19. Rothman KJ, Greenland S, Lash TL. Bias analysis. Modern epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008. p. 359.
20. Annan NT, Nelson M, Mandalia S, Bower M, Gazzard BG, Stebbing J. The nucleoside backbone affects durability of efavirenz-or nevirapine-based highly active antiretroviral therapy in antiretroviral-naive individuals. J Acquir Immune Defic Syndr. 2009;51:140-6.
21. Van Leth F, Andrews S, Grinsztejn B, Wilkins E, Lazanas MK, Lange JM, et al. The effect of baseline CD4 cell count and HIV-1 viral load on the efficacy and safety of nevirapine or efavirenz-based first-line HAART. AIDS. 2005;19:463-71.
22. Cozzi-Lepri A, Phillips AN, d'Arminio Monforte A, Piersantelli N, Orani A, Petrosillo N, Leoncini F, et al. Virologic and immunologic response to regimens containing nevirapine or efavirenz in combination with 2 nucleoside analogues in the Italian Cohort Naive Antiretrovirals (I.Co.N.A.) study. J Infect Dis. 2002; 185:1062-9.
23. Keiser P, Nassar N, White C, Koen G, Moreno S. Comparison of nevirapineand efavirenz-containing antiretroviral regimens in antiretroviral-naive patients: a cohort study. HIV Clin Trials. 2002;3:296-303.
24. Lockman S, Hughes M, McIntyre J, Zheng Y, Chipato T, Conradie F, et al. Antiretroviral therapies in women after single-dose nevirapine exposure. N Engl J Med. 2010;363:1499-509.